Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...

Learn the correct pronunciation of the Irbesartan and Hydrochlorothiazide , understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, ...

Review the side-effects of Irbesartan and Hydrochlorothiazide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...

Lupin Pharmaceuticals and the Food and Drug Administration have announced a recall of batches of irbesartan tablets and irbesartan hydrochlorothiazide tablets, used to treat high blood pressure. Some ...

A drug company announced on Friday that eight lots of Irbesatan blood pressure medication have been recalled after testing showed the medication contained trace amounts of a cancer-causing material.

Combination therapy using irbesartan and hydrochlorothiazide was shown to effectively lower blood pressure levels in a large group of hypertensive patients. “The INCLUSIVE [Irbesartan/HCTZ blood ...

The study was conducted in adult patients aged 18 years or older with moderate hypertension that at enrolment was either untreated for at least 4 weeks or uncontrolled by monotherapy. Monotherapy was ...

Rockville, MD - The US FDA Cardiovascular and Renal Drugs Advisory Committee recommended extended use of the combination product irbesartan plus hydrochlorothiazide (Avalide, Bristol-Myers Squibb) for ...

Prinston Pharmaceuticals has recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ, the company announced in a news release. The medications are used to control high blood pressure and ...

Clinical trials have shown that antihypertensive treatment with the angiotensin II receptor blocker (ARB) irbesartan is an effective way of lowering the BP, and the side effects are mild. 8 A number ...

A drug company announced on Friday that eight lots of Irbesatan blood pressure medication have been recalled after testing showed the medication contained trace amounts of a cancer-causing material.